| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/29/2013 | EP2595623A1 Use of delta tocopherol for the treatment of lysosomal storage disorders |
| 05/29/2013 | EP2595622A1 Medicaments based on dinuclear arene ruthenium complexes comprising bridging thiolato, selenolato or alkoxo ligands |
| 05/29/2013 | EP2595621A1 Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders |
| 05/29/2013 | EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 05/29/2013 | EP2595619A1 Methods of treating metastatic breast cancer with 4-iodo-3-nitrobenzamide and irinotecan |
| 05/29/2013 | EP2595618A1 Methods of treating breast cancer using 4-iodo-3-nitrobenzamide in combination with anti-tumor agents |
| 05/29/2013 | EP2595617A1 Topical treatment of neuropathic pain and methods of diagnosis |
| 05/29/2013 | EP2595616A2 Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | EP2595614A1 Composition for retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
| 05/29/2013 | EP2595613A1 Method of preventing or treating viral infection |
| 05/29/2013 | EP2595611A2 Multiple unit tablet composition |
| 05/29/2013 | EP2595608A2 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 05/29/2013 | EP2595607A2 Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer |
| 05/29/2013 | EP2595606A2 Method for preparing microspheres and microspheres produced thereby |
| 05/29/2013 | EP2595602A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 05/29/2013 | EP2595597A2 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules |
| 05/29/2013 | EP2595485A1 Methods of use cyclic amide derivatives to treat sigma receptor-mediated disorders |
| 05/29/2013 | EP2595484A1 Methods of use of cyclic amide derivatives to treat schizophrenia |
| 05/29/2013 | EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
| 05/29/2013 | EP2595482A1 Aldosterone synthase inhibitors |
| 05/29/2013 | EP2395991B1 Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| 05/29/2013 | DE19781981B3 Neue Pestizidkombination New pesticide combination |
| 05/29/2013 | DE112011102708T5 Verwendung von Bindemitteln zur Herstellung von lagerungsstabilen Formulierungen Use of binders for the preparation of storage stable formulations |
| 05/29/2013 | DE102012111562A1 Composition useful e.g. for relieving pain associated with otitis, comprises glycerol, butanediol, 2-isopropyl-5-methylphenol, lavender essential oil, choline salicylate and plant extract made of e.g. dried drug of marigold flower, ethanol |
| 05/29/2013 | DE102012000430A1 Topical composition, useful to avoid and/or reduce scar formation, comprises onion extract and panthenol and/or its derivatives, preferably esters and/or pantothenic acid and/or its salt |
| 05/29/2013 | DE102011055683A1 Synthetisches Schmiermittel zur Verwendung als Synovialflüssigkeitsersatz Synthetic lubricant for use as Synovialflüssigkeitsersatz |
| 05/29/2013 | CN1976934B Alkyl substituted indoloquinoxalines |
| 05/29/2013 | CN1968707B Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases |
| 05/29/2013 | CN1826121B Use of phenyl and pyridyl derivative for modulating calcium ion-release-activated calcium ion channels |
| 05/29/2013 | CN1747730B Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 05/29/2013 | CN1671643B Bipolar trans carotenoid salts and their uses |
| 05/29/2013 | CN1582165B Antibodies to CD40 |
| 05/29/2013 | CN1525866B Treatment using neublastin polypeptides |
| 05/29/2013 | CN103124735A 4-alkylresorcinol derivative and external preparation for skin containing same |
| 05/29/2013 | CN103124731A Fused heteroaryls and their uses |
| 05/29/2013 | CN103124729A Pharmaceutically active compounds as Axl inhibitors |
| 05/29/2013 | CN103124727A Substituted 3-phenyl-1,2,4-oxadiazole compounds |
| 05/29/2013 | CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use |
| 05/29/2013 | CN103124563A Combination therapy for the treatment of prostate carcinoma |
| 05/29/2013 | CN103124558A Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles |
| 05/29/2013 | CN103124557A 纯埃罗替尼 Pure erlotinib |
| 05/29/2013 | CN103124556A 贴剂 Patch |
| 05/29/2013 | CN103124555A Substrate of three-layer structure and water-containing adhesive patch including same |
| 05/29/2013 | CN103124498A Oral formulations of bipolar trans carotenoids |
| 05/29/2013 | CN103124496A Benzimidazole derivatives as PI3 kinase inhibitors |
| 05/29/2013 | CN103122019A Compounds useful for treating neurodegenerative disorders |
| 05/29/2013 | CN103122014A Clindamycin isomer, analytical preparation method and application thereof |
| 05/29/2013 | CN103122013A Hydrogen-removing clindamycin as well as analysis preparation method and application thereof |
| 05/29/2013 | CN103122004A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122003A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122002A Naphthoquinone compound with antitumor activity |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103122000A High-selectivity c-Met kinase inhibitor used as antitumor drug |
| 05/29/2013 | CN103121998A Vinpocetine compound and drug composition thereof |
| 05/29/2013 | CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors |
| 05/29/2013 | CN103121994A Salt of pyrrole derivative |
| 05/29/2013 | CN103121993A Salt of 2,6-dichloro-3-fluorophenyl derivative |
| 05/29/2013 | CN103121991A Aryl carboxylic acid imatinib derivative as well as preparation and application thereof |
| 05/29/2013 | CN103121990A Cinnamyl amide imatinib ramification as well as preparation method and application thereof |
| 05/29/2013 | CN103121986A Crystal form E of 7-hydroxyisoflavone and preparation method thereof, and pharmaceutical composition and application thereof |
| 05/29/2013 | CN103121985A Beta-adrenergic blocking agent based on soy isoflavone derivatives and preparation method and purpose thereof |
| 05/29/2013 | CN103121973A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121972A Pyrimidine urea derivatives as kinase inhibitors |
| 05/29/2013 | CN103121971A Salt for aryl urea derivant |
| 05/29/2013 | CN103121970A Benzimidazole and derivative thereof, and medicinal composition and application thereof in preparation of antidepressant medicaments |
| 05/29/2013 | CN103121969A Benzimidazole and derivative thereof, and medicinal composition and application thereof |
| 05/29/2013 | CN103121968A Salt of quinoline derivative |
| 05/29/2013 | CN103121965A Salts of indolone derivatives |
| 05/29/2013 | CN103120798A Preparation method and application of phospholipid complex with anti-oxidative stress |
| 05/29/2013 | CN103120796A Antitumor compound of dichloroacetic acid connected with alkaline antitumor drug |
| 05/29/2013 | CN103120795A Preparation targeting macrophages |
| 05/29/2013 | CN103120794A Pharmaceutic adjuvant with collaborative work and anti-tumor application thereof |
| 05/29/2013 | CN103120792A Drug for treating toothache |
| 05/29/2013 | CN103120778A External medicinal liquor |
| 05/29/2013 | CN103120763A Medicinal composition for treating sequela of cerebral apoplexy |
| 05/29/2013 | CN103120758A External Chinese medicinal preparation for burns and scalds |
| 05/29/2013 | CN103120757A Medicine for treating fire burn |
| 05/29/2013 | CN103120752A Chinese medicinal composition for treating oral ulcer |
| 05/29/2013 | CN103120749A Effective cough relief soup making method |
| 05/29/2013 | CN103120748A Traditional Chinese medicine for treating hepatitis |
| 05/29/2013 | CN103120746A Medicament for treating viral hepatitis |
| 05/29/2013 | CN103120739A Medicinal liquor with blood circulation accelerating health-care function and preparation method thereof |
| 05/29/2013 | CN103120736A Method for preparing medicinal preparation for treating apoplexy hemiplegia |
| 05/29/2013 | CN103120735A Medicinal composition for treating cerebral apoplexy hemiplegia |
| 05/29/2013 | CN103120733A Medicine for treating myocarditis |
| 05/29/2013 | CN103120729A Traditional Chinese medicine composition for treating whelk and acne rosacea, and preparation method of total tanshinones |
| 05/29/2013 | CN103120723A Traditional Chinese medicine composition for treating scalded, burned or cut wounds and preparation method thereof |
| 05/29/2013 | CN103120722A Dental ulcer powder |
| 05/29/2013 | CN103120714A Chinese medicinal preparation for treating suppurative otitis media |
| 05/29/2013 | CN103120712A Nanoemulsion spray for inflammation reducing and pain easing of wounds and preparation method of nanoemulsion spray |
| 05/29/2013 | CN103120704A Composition of acne therapeutic agent |
| 05/29/2013 | CN103120702A Application of gag including hydrophobic group in preparation of drug for preventing or treating epithelium |
| 05/29/2013 | CN103120701A Application of gag including hydrophobic group in preparation of drug for preventing or treating epithelium |
| 05/29/2013 | CN103120700A Method for preparing arisaema heterophyllum polysaccharide with anti-tumor activity |
| 05/29/2013 | CN103120699A Application of iridoid in preparation of anti-SARS (severe acute respiratory syndromes) medicines |
| 05/29/2013 | CN103120698A Application of triterpenoid saponins compound in preparation of anti-pathogenic microorganism medicines |
| 05/29/2013 | CN103120697A Application of squamatic acid to preparation of antitumor drugs |
| 05/29/2013 | CN103120696A Application of baeomycesic acid to preparation of antitumor drugs |
| 05/29/2013 | CN103120695A Application of Gypensapogenin B in medicine for reducing blood sugar |